The Charlson Comorbidity Index is an Independent Prognostic Factor for Treatment-Naïve Hepatocellular Carcinoma Patients with Extrahepatic Metastases.
Yueh-shih ChangJen-seng HuangCho-li YenCheng-hsu WangChien-hong LaiTsung-han WuYii-jeng LanPei-hung ChangKun-yun YehPublished in: Hepato-gastroenterology (2016)
The pre-treatment comorbidity status played an important role in overall survival because of its association with the administration of anti-cancer therapy. Therefore, comprehensive evaluation of comorbidities before treatment is recommended for HCC patients with extrahepatic metastases.
Keyphrases